A partial β-sarcoglycan (SG) deficiency with retention of other components of the SG complex (SGC) is described in 6-month-old, intact male domestic shorthaired kitten that was referred for evaluation of weakness, reluctance to move and dyspnoea. Neurological deficits were restricted to the neuromuscular system. Muscle biopsy revealed moderate variability in myofibre size, with numerous atrophic rounded fibres, rare myofibre necrosis, regeneration and moderate perimysial and endomysial fibrosis. Immunohistochemistry revealed decreased expression of β- and γ-SG and western blotting revealed markedly decreased β-SG with normal expression of α-, γ- and δ-SG, caveolin-3 and calpain-3. Sarcoglycanopathy has not previously been described in cats. In human and canine sarcoglycanopathies the deficiency in any one of the SGs leads to secondary deficiency of the entire SGC. Such spontaneously arising muscular disease in animals can provide valuable models for equivalent human disorders.

Muscular Dystrophy with Reduced β-Sarcoglycan in a Cat / C. Salvadori, G. Vattemi, R. Lombardo, M. Marini, C. Cantile, G.D. Shelton. - In: JOURNAL OF COMPARATIVE PATHOLOGY. - ISSN 0021-9975. - 140:4(2009), pp. 278-282. [10.1016/j.jcpa.2008.12.003]

Muscular Dystrophy with Reduced β-Sarcoglycan in a Cat

R. Lombardo;
2009

Abstract

A partial β-sarcoglycan (SG) deficiency with retention of other components of the SG complex (SGC) is described in 6-month-old, intact male domestic shorthaired kitten that was referred for evaluation of weakness, reluctance to move and dyspnoea. Neurological deficits were restricted to the neuromuscular system. Muscle biopsy revealed moderate variability in myofibre size, with numerous atrophic rounded fibres, rare myofibre necrosis, regeneration and moderate perimysial and endomysial fibrosis. Immunohistochemistry revealed decreased expression of β- and γ-SG and western blotting revealed markedly decreased β-SG with normal expression of α-, γ- and δ-SG, caveolin-3 and calpain-3. Sarcoglycanopathy has not previously been described in cats. In human and canine sarcoglycanopathies the deficiency in any one of the SGs leads to secondary deficiency of the entire SGC. Such spontaneously arising muscular disease in animals can provide valuable models for equivalent human disorders.
animal model; cat; muscular dystrophy; sarcoglycan deficiency
Settore VET/09 - Clinica Chirurgica Veterinaria
2009
Article (author)
File in questo prodotto:
File Dimensione Formato  
Muscular Dystrophy with Reduced b-Sarcoglycan in a Cat.pdf

accesso riservato

Descrizione: articolo pubblicato in pdf
Tipologia: Publisher's version/PDF
Dimensione 327.67 kB
Formato Adobe PDF
327.67 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/750674
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 12
social impact